- Home | Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes
- Company | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities
- Biogen Inc. (BIIB) Stock Price, News, Quote History - Yahoo Finance
Biogen Inc discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally
- Biogen to Advance Investigational Spinal Muscular Atrophy Asset to . . .
The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts
- Biogen
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while
- Biogen Trial Link
Through Biogen Trial Link, we hope to connect patients, caregivers and healthcare professionals with education and information about our clinical trials Click to learn more
- Biogen US Medical Information Website
This website provides US healthcare professionals (HCPs) with evidence-based scientific responses to unsolicited medical questions about Biogen products The information is provided for educational purposes only and is not intended to be promotional nor provide medical advice
- Pipeline | Biogen
Biogen is dedicated to addressing challenging diseases by leveraging cutting-edge science and driving an innovative pipeline of potential breakthrough therapies in neurology, immunology, and rare diseases
|